Limit Placebo Use in Cancer Clinical Trials, Says FDA Limit Placebo Use in Cancer Clinical Trials, Says FDA

In a new draft guidance, the FDA recommends limiting the use of placebo in oncologic clinical trials because it poses both practical and ethical concerns.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news